Screening Colonoscopy Converted to Diagnostic With Polypectomy
A 58-year-old Medicare Part B patient presents for a screening colonoscopy. She is average risk, asymptomatic, and her last screening 10 years ago was normal. The referral diagnosis is Z12.11. During the colonoscopy the gastroenterologist finds two 8 mm sessile polyps in the transverse colon and removes both with a snare, then finds a 4 mm polyp in the sigmoid colon and removes it with cold forceps. The endoscope is advanced to the cecum and the preparation is documented as adequate. Pathology returns tubular adenomas. The patient has already met her Part B deductible this year. The coder is entering the claim and is unsure whether to use the screening HCPCS code, whether the procedure is still treated as screening for payment, and how many procedure lines to submit for the two different removal techniques.
1. Determine the procedure code lines and modifiers for this colonoscopy.
Read the worked answer
The test started as a screening but became diagnostic the moment a polyp was found and removed, so the screening HCPCS code (G0121) is no longer correct. Report the therapeutic colonoscopy codes and add modifier PT so the payer knows the service began as a screening. Under Medicare, PT preserves any screening-related cost-sharing waiver for the screening portion and flags the conversion.
Line 1: 45385-PT for the snare polypectomy in the transverse colon - snare removal is the most comprehensive technique used. Both transverse polyps were in the same segment and removed by the same technique, so the code is reported once; do not multiply it for the second polyp.
Line 2: 45380 for the sigmoid cold-forceps polypectomy, at a different anatomic site and by a different technique. This pair is subject to a national correct coding edit, so confirm the edit's modifier indicator before billing. If the indicator permits it, append 59, or preferably the more specific XS for a separate site, and attach a note identifying the sigmoid location. If the payer's edit does not allow separation, bill 45385 only and do not pursue the second line.
2. Sequence the diagnosis codes and explain why the screening code is retained at all if the service is now diagnostic.
Read the worked answer
Report Z12.11 first-listed, followed by K63.5 for the colonic polyps. Some coders want to drop Z12.11 because the procedure became therapeutic, but ICD-10-CM guidelines direct that when a screening is converted to a diagnostic or therapeutic procedure, the screening code remains first-listed and the finding is added as a secondary code. Pathology confirmation of tubular adenoma does not displace this rule; K63.5 is supported by the documented polyps.
Keeping Z12.11 first also does real payment work. It gives the payer the reason the test was originally ordered, which is what supports the screening benefit and interacts with the PT modifier. If Z12.11 is omitted, some Medicare administrative contractors will process the claim as purely diagnostic and apply cost-sharing the patient does not owe for the screening component.
If a polyp had been found but not removed, Z12.11 plus K63.5 would still apply and the procedure code would be a diagnostic colonoscopy with biopsy if a specimen was taken. Order of codes drives both medical necessity and beneficiary liability, so it is not a cosmetic choice.
3. How would the coding differ if this patient were covered by a commercial plan, or if she had a first-degree relative with colon cancer at age 45?
Read the worked answer
Commercial plan: replace PT with modifier 33, the preventive services modifier used when the primary purpose of the service was preventive. Many commercial plans waive cost-sharing for screening colonoscopy only when 33 is present, and a claim with a polyp diagnosis but no 33 is frequently processed as diagnostic with full patient responsibility. If the plan insists on a screening diagnosis to trigger the benefit, follow the plan's own policy - some require Z12.11 only, others want the polyp coded as well. Verify before billing; do not guess.
High-risk patient: a first-degree relative with colon cancer at 45 makes her high risk rather than average risk. For Medicare that means G0105 for high-risk screening and Z80.0 (family history of malignant neoplasm of the digestive tract) as the diagnosis, instead of Z12.11 and the average-risk pathway. Documentation of the family history must be in the record - the coder cannot infer it from the referral alone.
In both variations the conversion, the two techniques, and the separate sites still drive the procedure coding exactly as in the main scenario. Only the screening modifier and the first-listed diagnosis change.